EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex:AIS), a leader in self injection drug delivery technology, today announced that the Company’s shares have been added to the Russell 3000® Index in conjunction with the reconstitution of the index. Membership in the Russell 3000® remains in place for one year. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.
